See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: May 3, 2006

Depression (Major/Severe) Insomnia Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric) and Insomnia

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Depression (Major/Severe)

This research study of recurrent early-onset depression is sponsored by the U.S. National Institute of Mental Health. You may qualify to participate if your depression started by age 30, you had more than one period of depression, and at least one immediate family member (brother, sister, or parent) who also has had repeated periods of depression. The research sites are in the central United States.

More information

Please see



This research study is evaluating an investigational medication for insomnia. Candidates 65 or older who have at least a 3-month history of sleep problems and are in good general health may be eligible. Participants may be compensated for time and travel. Research sites are located throughout the United States.

More information

Please see


Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric) and Insomnia

This is a clinical research study of patients with ADHD and difficulty falling asleep or staying asleep. Children 6-17 with diagnosed ADD or ADHD who have been on a stable ADHD therapy for at least one month and have problems sleeping may be eligible. If enrolled, your child will receive study-related medication or non-medicinal placebo and sleep evaluation at no cost. The research site is in Temecula, Calif.

More information

Please see and


Copyright 2006 CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.